Market News & Trends
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site. Along…
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site. Along…
GW Pharmaceuticals Achieves Positive Results in Phase II Study
GW Pharmaceuticals plc recently announced positive top-line results from an exploratory Phase II placebo-controlled clinical study of a proprietary combination of tetrahydrocannabinol (THC) and cannabidiol…
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.…
Galectin Presents Clinical Data of Combination Immunotherapy With Galectin-3 Inhibitor GR-MD-02
Galectin Therapeutics Inc. and the Providence Cancer Center recently announced the presentation of preclinical and early clinical data from two investigator-initiated Phase I clinical trials…
Q BioMed, Oklahoma Medical Research & Rajiv Gandhi Centre to Develop Chemotherapeutic Technology
Q BioMed, Inc. has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB) to develop…
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.…
Lupus R&D Landscape Set to be Dominated by Big Pharma & Small Biotech Partnerships
The lupus market, which is set to reach $3.2 billion by 2025 and has historically been dominated by inexpensive generic drugs, will see a future…
MedCrypt & QuiO Partner on Device Security for Safe Transfer of Prescriptions & Injection Data
MedCrypt, an early stage medical device software security company, and QuiO, an early stage connected therapeutics company, recently announced an integration partnership for the Smartinjector…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Next-Generation Silicone Adhesive Technologies Key to Broader Global Adoption, Growth of Wearable Medical Devices
According to Grand View Research, the global market for wearable medical devices is expected to reach $27.8 billion by 2022.1 Dow Corning, a global leader…
Advaxis’ GOG-0265 Study in Metastatic Cervical Cancer Selected for Late-Breaking Data Presentation
Advaxis, Inc. recently announced that an abstract on data from the company’s Phase II GOG-0265 trial evaluating axalimogene filolisbac for metastatic cervical cancer has been…
Gerresheimer Optimizes Cold-End Operations at its Pharma Glass Production Plants With State-of-the-Art Packing Robots
Every year, Gerresheimer’s pharmaceutical industry customers order several hundreds of millions of glass pharmaceutical packaging products manufactured at the company’s plants in Essen and Lohr.…
Incyte & Calithera Biosciences Announce Global Collaboration
Incyte Corporation and Calithera Biosciences, Inc. recently announced the companies have entered into a global collaboration and license agreement for the research, development, and commercialization…
Gemphire Announces Interim LDL-C Lowering Data From Clinical Trial
Gemphire Therapeutics Inc. recently announced interim data on the LDL-C primary endpoint from the ongoing open label COBALT-1 trial. COBALT-1 is investigating gemcabene in homozygous familial…
First Clinical Milestone Achieved in Collaboration Between AbCheck & Lilly
AbCheck s.r.o., a technology company focusing on the discovery and optimization of high-quality human antibodies, recently announced the achievement of the first clinical milestone in…
Abeona Therapeutics Enrolls First High-Dose Subject in Ongoing Phase I/II Trial
Abeona Therapeutics Inc. recently announced that the first high-dose subject was enrolled in the ongoing Phase I/II trial for ABO-102 (AAV-SGSH). The first-in-man clinical trial…
